Crossmark

Application of CHyMErA Cas9-Cas12a combinatorial genome-editing platform for genetic interaction mapping and gene fragment deletion screening

Published Online: 2021-09-10

Published Print: 2021-10

Authors

Aregger, Michael https://orcid.org/0000-0001-6443-9870
Xing, Kun https://orcid.org/0000-0001-7074-5217
Gonatopoulos-Pournatzis, Thomas https://orcid.org/0000-0003-2669-2570
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute
License Information

Text and Data Mining valid from 2021-09-10

Version of Record valid from 2021-09-10
More Information

Article History

Received: 28 November 2020

Accepted: 17 June 2021

First Online: 10 September 2021

Competing interests

: A patent application (no. GB 1907733.8) describing the development and applications of CHyMErA is pending.

Document is current